Y. Joseph Mo
12Patents
4h-index
13Co-inventors
53Inventor score
Filing activity: Apr 2, 2001 → Mar 30, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6841574B2 | Topical stabilized prostaglandin E compound dosage forms | Human Necessities | 23 | Expired |
| US6594527B2 | Electrical stimulation apparatus and method | Human Necessities | 17 | Expired |
| US7462362B2 | Antifungal nail coat and method of use | Emerging Cross-Sectional Technologies | 16 | Expired |
| US8841345B2 | Compositions and methods for treatment of premature ejaculation | Human Necessities | 11 | Active |
| US8632813B2 | Prostaglandin compositions and methods for the treatment of vasospasm | Human Necessities | 3 | Active |
| US9066854B2 | Alprostadil and dyclonine for treatment of premature ejaculation | Human Necessities | 1 | Active |
| US9060929B2 | Alprostadil for treatment of premature ejaculation | Human Necessities | 0 | Active |
| US9693970B2 | Transdermal drug delivery system containing donepezil | Human Necessities | 0 | Active |
| US11246932B2 | Prostaglandin compositions and methods for the treatment of vasospasm | Human Necessities | 0 | Active |
| US9155711B2 | Transdermal drug delivery system containing donepezil | Human Necessities | 0 | Active |
| US9056044B2 | Alprostadil and lidocaine treatment of premature ejaculation | Human Necessities | 0 | Active |
| US10195408B2 | Transdermal drug delivery system containing donepezil | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.